Keywords: European Commissioners, Changes, DG Enterprise and Industry, DG Sanco, EFPIA, EPHA

Changes at European Commission see Pharma under control of Health and Consumer policy portfolio

Article | 1 December 2009

Jose Manuel Barroso, President of the European Commission, has announced the portfolios responsibilities for the next Commission, among which he has decided to follow recommendations from the public health community in terms of transfer of pharmaceutical policy from the portfolio of the Entreprise and Industry Commissioner to that of the Health and Consumer, DG Sanco.

John Dalli, now Minister for Social Policy in Malta, will be given almost all-important competencies, in the area of biotechnology in the next European Commission. Enjoying this article? To continue reading you need to login, take a FREE trial or subscribe.

FREE unlimited, no obligation access to The Pharma Letter website for 30 days, normally worth £60!

Sign up in less than 60 seconds...no payment needed

Want to read the full article?
Take a 30 day FREE Trial worth £60

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in